Background: Population studies show that musculoskeletal conditions are a leading contributor to the total burden of healthy life lost, second only to cancer and with a similar burden to cardiovascular disease. Prioritizing the delivery…
Continue Reading
What You Should Know:
– Alfred Health, a Victorian healthcare network, has expanded its partnership with Oracle Health by implementing the Oracle Oncology EHR solution. This move marks a significant step forward in providing comprehensive…
Continue Reading
East and North Hertfordshire NHS Trust has become the first trust in the UK to adopt the Dedalus ORBIS U electronic patient record (EPR).
ORBIS U enables patient information, including medical history, diagnoses, medications, treatment…
The first patients have been scanned by a new £3.6m gamma camera at The Shrewsbury and Telford NHS Hospital Trust (SaTH).
The camera, which SaTH said is the single largest investment in “nuclear medicine” made…
What You Should Know: – Absci Corporation, a leader in generative AI drug creation, today announced a strategic collaboration with Memorial Sloan Kettering Cancer Center (MSK) to develop up to six novel cancer therapeutics. …
Continue Reading
Korea opens access to cancer data of 2 million patientsResearchers in South Korea can now access an expanded big-data repository on 2.26 million cancer patients.
The Korean Ministry of Health and Welfare (MOHW), together with…
What You Should Know: – Pangea Biomed, the startup behind the world’s most advanced cancer response predictor, ENLIGHT, is announcing a strategic collaboration with the Sharett Institute of Oncology and Hadassah Cancer Research Institute…
Continue Reading
In this case study, Plexaa, an alumnus company of the Accelerating FemTech programme, shares how their patented supraphysiological preconditioning device, BLOOM43, will ensure positive wound healing outcomes for patients undergoing breast cancer surgery. Overview Out of…
Continue Reading
Introduction
The Dana-Farber Cancer Institute (DFCI) has taken significant strides in integrating large language models (LLMs) into its operations, focusing on non-clinical applications. This initiative, led by Renato Umeton, the Director of AI Operations and…
The famous Dana-Farber Cancer Institute built a secure and private exploratory environment to evaluate, test and deploy large language models for non-clinical applications such as clinical and basic research and operations.The provider organization overcame…
Continue Reading
